Most of these new technologies against cancer still have to prove their efficacy in clinical trials.
Immunotherapy is a new area of cancer treatment that uses the immune system to attack cancer cells.
Immunotherapeutic vaccines in this treatment immune system cells are removed from the patient's blood and are sent to a lab. At the lab, the cells are exposed to chemicals that turn them into special immune cells called dendritic cells, this therapy is in clinical trials on several forms of cancer.
Monoclonal antibodies (mAbs) are antibodies designed by researchers to attack specific antigens, such as the ones found in cancer.
Adoptive cell transfers involve removing immune system cells (usually white blood cells) from a patient's body, re-engineering them to teach them how to fight against specific forms of cancerous cells and then re-infusing them back into the patient's body
Gene therapy one of which is CAR T-cell therapy where doctors take the cells out of your blood and change them by adding new genes so they can better find and kill cancer cells.
Interventional radiology involves minimally invasive techniques using needles and catheters and provides an alternative to surgery for some patients.
Hyperthermia therapy, the application of heat to treat certain medical conditions, including possible tumors, has a very long history. This experimental form of cancer therapy utilizes localized or whole-body administration of heat rapidly killing the cells within a tumor.
One treatment involves injecting metallic nanoparticles, including gold, carbon nanotubes, or zinc ferrite, into the tumor. Doctors would then heat these nanoparticles up using magnetic fields or radio waves, killing the surrounding cancer cells.
High-Intensity Focused Ultrasound (HIFU) treatment uses focused sound waves to destroy cancerous cells in the bone, brain, breast, liver, pancreas, rectum, kidneys, testes, and prostate.
Artificial intelligence is being used in computer modeling of Multiparametric-magnetic resonance imaging giving the ability to detect cancer cells where the human review has less accuracy.
Mutations are random. If you look at one patient’s tumor and compare it to another patient’s, it would be highly unlikely that there will be a match. It used to be that most people with a certain type and stage of cancer got the same treatment. Doctors know that a solution that helps one person may not work well for someone else, now with personalized medicine, we are adapting to these variations. The microbiome plays an important role in all care models.
Elements of the microbiome play a role in suppressing an overactive immune system in inflammatory diseases, and in boosting a suppressed immune system in cancers.